Glenn Welling Engaged Capital
Glenn Welling is the founder of Engaged Capital, an activist investment firm focused primarily on small- and mid-cap U.S. companies. Engaged Capital seeks undervalued businesses where operational improvement, cost discipline, or strategic change can unlock value. Welling’s campaigns are closely watched in the activist community for mid-market corporate engagement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hain Celestial
HAIN
|
+$98.3M |
| 2 |
STKL
SunOpta
STKL
|
+$7.26M |
| 3 |
Medifast
MED
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Benchmark Electronics
BHE
|
+$48.5M |
| 2 |
Anika Therapeutics
ANIK
|
+$12.6M |
| 3 |
Groupon
GRPN
|
+$7.83M |
| 4 |
PETX
Aratana Therapeutics, Inc.
PETX
|
+$4.64M |
| 5 |
Astec Industries
ASTE
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 58.96% |
| 2 | Technology | 21.01% |
| 3 | Industrials | 13.5% |
| 4 | Healthcare | 3.33% |
| 5 | Consumer Discretionary | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Hain Celestial
HAIN
$71.6M
| $390M | 54.72% |
16,861,212
+5,099,970
| +43% | +$98.3M |
|
2
Upbound Group
UPBD
$1.1B
| $111M | 15.62% |
5,333,609
| – | – |
|
3
Apogee Enterprises
APOG
$868M
| $63.3M | 8.89% |
1,689,332
| – | – |
|
|
STKL
4
DELISTED
SunOpta
STKL
| $30.2M | 4.24% |
8,731,907
+1,875,000
| +27% | +$7.26M |
|
5
NCR Voyix
VYX
$1.09B
| $29.4M | 4.12% |
1,754,635
| – | – |
|
|
TIVO
6
DELISTED
Tivo Inc
TIVO
| $23.5M | 3.3% |
2,525,000
| – | – |
|
|
DFRG
7
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $21.3M | 2.99% |
3,328,000
| – | – |
|
|
MGLN
8
DELISTED
Magellan Health Services, Inc.
MGLN
| $15M | 2.11% |
227,558
-28,203
| -11% | -$1.81M |
|
|
INWK
9
DELISTED
InnerWorkings, Inc.
INWK
| $9.35M | 1.31% |
2,582,346
| – | – |
|
|
10
Benchmark Electronics
BHE
$2.61B
| $9.03M | 1.27% |
343,873
-1,892,914
| -85% | -$48.5M |
|
|
PETX
11
DELISTED
Aratana Therapeutics, Inc.
PETX
| $8.7M | 1.22% |
2,417,149
-1,070,000
| -31% | -$4.64M |
|
|
12
Medifast
MED
$134M
| $1.43M | 0.2% |
+11,242
| New | +$1.43M |
|
|
13
Anika Therapeutics
ANIK
$291M
| – | – |
-374,926
| Closed | -$12.6M |
|
|
14
Astec Industries
ASTE
$1B
| – | – |
-73,605
| Closed | -$2.22M |
|
15
Babcock & Wilcox
BW
$1.23B
| – | – |
-377,472
| Closed | -$1.47M |
|
|
16
Groupon
GRPN
$797M
| – | – |
-122,270
| Closed | -$7.83M |
|
Similar funds
Glenn Welling's Q1 2019 Portfolio in Review
As of Q1 2019, Glenn Welling held 16 positions worth $712M, up 32% from $539M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Glenn Welling deployed $27.9M of net new capital in Q1 2019, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Medifast: 11,242 shares worth $1.43M.
By sector, the portfolio is most concentrated in Consumer Staples at 59% of assets, up from 40% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Benchmark Electronics, an estimated $48.5M trimmed.
- Glenn Welling's largest Q1 2019 buy was Medifast: 11,242 shares worth $1.43M.
- Glenn Welling added most to Hain Celestial in Q1 2019, an estimated $98.3M increase.
- Glenn Welling's biggest Q1 2019 reduction was Benchmark Electronics, cutting an estimated $48.5M.
- Glenn Welling fully exited Anika Therapeutics in Q1 2019, selling an estimated $12.6M.
- Glenn Welling's ten largest holdings make up 99% of its $712M portfolio in Q1 2019.
- Glenn Welling opened 1 new position and closed 4 in Q1 2019.
- Glenn Welling's portfolio value rose 32% quarter-over-quarter to $712M.
Based on Engaged Capital's 13F filing for Q1 2019, filed 15 May 2019.